What are the concerns with lamotrigine (anticonvulsant) use in a 17-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lamotrigine in a 17-year-old girl requires careful monitoring due to potential concerns, including severe skin reactions, suicidal thoughts, and interactions with hormonal contraceptives, which can decrease lamotrigine levels and reduce its effectiveness. The primary concern is the risk of severe skin reactions, particularly Stevens-Johnson syndrome and toxic epidermal necrolysis, which are more common in pediatric patients and young adults 1. These reactions typically occur within the first 8 weeks of treatment, necessitating a slow titration schedule starting at 25mg daily for 2 weeks, then 50mg daily for 2 weeks, before gradually increasing to the therapeutic dose.

  • Key concerns with lamotrigine in adolescent girls include:
    • Severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis
    • Increased risk of suicidal thoughts and behaviors
    • Interactions with hormonal contraceptives, which can decrease lamotrigine levels and reduce its effectiveness
    • Cognitive side effects, such as dizziness, headache, and coordination problems, that could affect school performance
    • Compliance with the medication regimen, which may be challenging for adolescents Another significant concern is the increased risk of suicidal thoughts and behaviors in adolescents taking antiepileptic drugs like lamotrigine, requiring close monitoring for mood changes, depression, or unusual behaviors 1. Hormonal contraceptives can decrease lamotrigine levels, potentially reducing its effectiveness, which is particularly relevant for adolescent girls who may be using birth control, as noted in studies on drug interactions and contraceptive use 1. Regular blood level monitoring is recommended to ensure therapeutic dosing. Additionally, lamotrigine may cause cognitive side effects such as dizziness, headache, and coordination problems that could affect school performance. Finally, compliance with the medication regimen may be challenging for adolescents, making education about the importance of consistent dosing and gradual dose changes essential to prevent complications.

From the Research

Concerns with Lamotrigine in a 17-Year-Old Girl

  • Efficacy and Safety: Studies have shown that lamotrigine can be effective in adolescents with mood disorders, with improvement seen in 52% of subjects in one study 2. Another study found that lamotrigine was well tolerated and effective in pediatric patients with mood disorders, with no major significant side effects and no cases of Stevens-Johnson syndrome 3.
  • Risk of Rash: There is a significant risk of benign rash associated with lamotrigine, with 10% of subjects developing a rash in one study 2. However, another study found that the risk of cutaneous reactions was not increased with the combination of lamotrigine and valproate 4.
  • Dosing and Concentration: The dosing of lamotrigine in children can be complex, with a high percentage of children having low trough concentrations 5. It is recommended to aim for the higher range of doses to reach the target concentration. Additionally, the concentration of lamotrigine can increase significantly after the addition of valproate, and therapeutic drug monitoring should be performed at the earliest from 14 days after starting valproate 4.
  • Combination Therapy: The combination of lamotrigine and valproate can be well tolerated and effective, with a high long-term retention rate 4. However, the exchange of lamotrigine with valproate can be complicated by adverse events, and a cautious switch is recommended 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lamotrigine in adolescent mood disorders: a retrospective chart review.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.